| mRNA surveillance pathway |
1.81 |
4.61e-2 |
71/98 (72.45%) |
FUS;PPP2R1B;PPP2R5A;...
|
| Inflammatory bowel disease |
-1.66 |
4.93e-2 |
58/65 (89.23%) |
RORA;HLA-DPB1;HLA-DQB1;...
|
| Pentose and glucuronate interconversions |
-1.69 |
4.10e-2 |
17/34 (50%) |
SORD;RPE;CRYL1;...
|
| Viral myocarditis |
-1.70 |
3.64e-2 |
53/60 (88.33%) |
CD86;CD55;RAC2;...
|
| Nitrogen metabolism |
-1.72 |
3.35e-2 |
16/17 (94.12%) |
CA9;CA4;CA8;...
|
| Hematopoietic cell lineage |
-1.74 |
2.92e-2 |
90/99 (90.91%) |
KITLG;ITGA2;CD5;...
|
| Oxidative phosphorylation |
-1.74 |
3.18e-2 |
93/133 (69.92%) |
NDUFS7;ATP4A;ATP5F1E;...
|
| Galactose metabolism |
-1.75 |
2.97e-2 |
26/31 (83.87%) |
GLB1;PFKP;AKR1B10;...
|
| Parkinson disease |
-1.78 |
2.36e-2 |
176/249 (70.68%) |
NDUFS1;PSMA6;NDUFB4;...
|
| Intestinal immune network for IgA production |
-1.78 |
2.65e-2 |
38/48 (79.17%) |
ITGA4;CXCL12;CD86;...
|
| Graft-versus-host disease |
-1.81 |
1.67e-2 |
32/42 (76.19%) |
HLA-A;HLA-F;HLA-DOB;...
|
| Antigen processing and presentation |
-1.89 |
8.85e-3 |
60/78 (76.92%) |
HSPA4;CD8A;HSP90AA1;...
|
| Ribosome |
-1.90 |
6.37e-3 |
113/158 (71.52%) |
RPS13;RPS12;RPS4Y1;...
|
| Allograft rejection |
-1.91 |
7.96e-3 |
32/38 (84.21%) |
HLA-A;HLA-F;HLA-DOB;...
|
| Asthma |
-1.97 |
0.00e+0 |
25/31 (80.65%) |
FCER1A;HLA-DPB1;HLA-DQB1;...
|
| Autoimmune thyroid disease |
-2.00 |
0.00e+0 |
46/53 (86.79%) |
HLA-A;HLA-F;HLA-DOB;...
|
| Type I diabetes mellitus |
-2.05 |
0.00e+0 |
38/43 (88.37%) |
HLA-A;HLA-F;HLA-DOB;...
|